Can Psoriatic Arthritis Cause Fever During a Flare?
Yes, psoriatic arthritis can cause fever during disease flares, though this is an atypical presentation that occurs in a distinct subgroup of patients and should prompt evaluation to rule out infection first.
Clinical Recognition and Presentation
Fever as an initial or prominent manifestation of psoriatic arthritis is well-documented but uncommon. When PsA presents with fever, it typically occurs in peripheral spondyloarthritis variants and is accompanied by severe systemic inflammatory responses 1, 2.
Key Clinical Features of Febrile PsA:
- Peripheral joint involvement predominates (65.4% of febrile cases vs 24% in typical PsA) 2
- Marked elevation of inflammatory markers:
- White blood cell count: ~11.6 cells/μL (vs 7.8 in non-febrile PsA)
- ESR: ~69 mm/h (vs 41 mm/h)
- CRP: ~110 mg/L (vs 15 mg/L) 2
- Leukocytosis and thrombocytosis are common 1
- Lower HLA-B27 positivity (52% vs 77% in typical PsA) 2
Critical Diagnostic Approach
The most important clinical pitfall is mistaking febrile PsA for septic arthritis or systemic infection. These patients often require hospitalization and extensive infectious workup 1.
Algorithmic Evaluation:
First priority: Rule out infection
- Blood cultures, synovial fluid analysis if joint effusion present
- Comprehensive infectious disease workup
Exclude other fever-associated rheumatic diseases:
- Adult-onset Still's disease
- Reactive arthritis
- Crystal arthropathies 1
Look for SpA-specific features:
- Peripheral arthritis pattern
- Enthesitis or dactylitis
- Psoriatic skin or nail involvement
- Inflammatory back pain
- Consider HLA-B27 testing and sacroiliac joint imaging 2
Management Implications
Febrile PsA patients require more aggressive initial management compared to typical PsA presentations:
- Higher rates of systemic corticosteroid use (57.7% vs 11%) 2
- Conventional DMARDs (methotrexate, sulfasalazine) are first-line 1
- TNF inhibitors may be needed in addition to conventional DMARDs for disease control 1
- These patients are significantly less likely to be referred to rheumatology early (7.7% vs 59%), leading to diagnostic delays 2
Clinical Context
While major PsA guidelines 3, 4 define active disease based on swollen joints, tender joints, dactylitis, enthesitis, and extraarticular manifestations, fever is not listed as a standard disease activity parameter. However, the research evidence clearly demonstrates that a subset of PsA patients—particularly those with peripheral spondyloarthritis—can present with fever and severe systemic inflammation 1, 2.
Recognition of this atypical presentation is crucial to avoid prolonged diagnostic delays and ensure appropriate rheumatologic evaluation once infection has been excluded.